180
Participants
Start Date
December 31, 2008
Primary Completion Date
May 31, 2013
Study Completion Date
May 31, 2013
placebo
paper support for glycaemia face to face visit at T4mounths
IVS
"patients transmit their glycaemia to the IVS, which advises them the insulin amount recommended by their physician in this situation.~Face to face visit at T4mounths plus telephone visits each 2 weeks."
PDAphone
Patients will receive PDA phone system. They will hace face to face visit at T4mounths and telephone visits each 2 weeks
CHU Marseille-Hôpital Nord, Marseille
CH Aix en Provence, Aix-en-Provence
CHU Marseille Hôpitaux Sud, Marseille
CHU de Caen, Caen
CH La Rochelle, La Rochelle
CHU Jean Minjoz, Besançon
CH de Dreux, Dreux
CHU de Nimes, Nîmes
Hopital Haut Leveque, Pessac
CHU Rennes, Rennes
University Hospital Grenoble, Grenoble
CHU de Saint Etienne, Saint-Etienne
CHU Nantes, Nantes
CH de l'Agglomération Montargoise, Montagis
CHU Hôpital Jeanne d'Arc, Nancy
Ch Valenciennes, Valenciennes
Centre Hospitalier Intercommunal Alençon-Mamers, Alençon
Hôpital Gabriel Montpied, Clermont-Ferrand
Centre Hospitalier Strasbourg, Strasbourg
Hopital COCHIN, Paris
CH Avignon, Avignon
CHU de Poitiers, Poitiers
Centre Hospitalier de Belfort Montbéliard, Belfort
CH sud francilien, Corbeil-Essonnes
CH Nanterre, Nanterre
Hôpital Bégin, Saint-Mandé
CHU de Bicêtre, Le Kremlin-Bicêtre
CHU Pierre Zobda-Quitman, Fort de France
Collaborators (1)
Novo Nordisk A/S
INDUSTRY
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
OTHER